Procter & Gamble (PG) Gains After Moving Up Earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Procter & Gamble (PG) PT Lowered to $75 at JPMorgan
April 20, 2018 8:23 AM EDTJPMorgan lowered its price target on Procter & Gamble (NYSE: PG) to $75.00 (from $80.00) while maintaining a Neutral rating following the company's 3Q earnings report. PGs reported organic sales growth of +1% was a 100bps sequential deceleration on reported figures from 2Q. Management now expects... More
Procter & Gamble (PG) Acquires Merck KGaA's Consumer Health Unit for Approx. $4.2B
April 19, 2018 6:01 AM EDTThe Procter & Gamble Company (NYSE: PG) today announced it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for a purchase price of approximately 3.4 billion euro.
This acquisition enables P&G to expand its successful consumer health care business by adding a fast-growing portfolio of differentiated, physician-supported brands across a broad geographic footprint. It also provides P&G with strong health care commercial and supply capabilities, deep technical mastery... More
